Skip to main content

INTUITIVE SURGICAL INC

For the period ended Dec 31, 2023. Filed Jan 31, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Jan 31, 2024

ISRG$460.56+1.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

INTUITIVE SURGICAL, INC.
By:/S/ GARY S. GUTHART
Gary S. Guthart, Ph.D.Chief Executive Officer

Date: January 31, 2024

Power of Attorney

Each person whose individual signature appears below hereby authorizes and appoints Gary Guthart, Ph.D., and Jamie Samath, and each of them, with full power of substitution and re-substitution and full power to act without the other, as his or her true and lawful attorney-in-fact and agent to act in his or her name, place, and stead and to execute in the name and on behalf of each person, individually and in each capacity stated below, and to file any and all amendments to this annual report on Form 10‑K and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing, ratifying and confirming all that said attorneys-in-fact and agents or any of them or their or his substitute or substitutes may lawfully do or cause to be done by virtue thereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

SignatureTitleDate
/S/ GARY S. GUTHARTChief Executive Officer and Director (Principal Executive Officer)January 31, 2024
Gary S. Guthart, Ph.D.
/S/ JAMIE E. SAMATHSenior Vice President and Chief Financial Officer (Principal Financial Officer)January 31, 2024
Jamie E. Samath
/S/ FREDRIK C. WIDMANVice President, Corporate Controller (Principal Accounting Officer)January 31, 2024
Fredrik C. Widman
/S/ CRAIG H. BARRATTChairman of the Board of DirectorsJanuary 31, 2024
Craig H. Barratt, Ph.D.
/S/ JOSEPH C. BEERYDirectorJanuary 31, 2024
Joseph C. Beery
/S/ AMAL M. JOHNSONDirectorJanuary 31, 2024
Amal M. Johnson
/S/ DON R. KANIADirectorJanuary 31, 2024
Don R. Kania, Ph.D.
/S/ SREELAKSHMI KOLLIDirectorJanuary 31, 2024
Sreelakshmi Kolli
/S/ AMY L. LADDDirectorJanuary 31, 2024
Amy L. Ladd, Ph.D.
/S/ KEITH R. LEONARD JR.DirectorJanuary 31, 2024
Keith R. Leonard Jr.
/S/ ALAN J. LEVYDirectorJanuary 31, 2024
Alan J. Levy, Ph.D.
/S/ JAMI DOVER NACHTSHEIMDirectorJanuary 31, 2024
Jami Dover Nachtsheim
/S/ MONICA P. REEDDirectorJanuary 31, 2024
Monica P. Reed
/S/ MARK J. RUBASHDirectorJanuary 31, 2024
Mark J. Rubash
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.